Regenicin, Inc. (RGIN) SEC Filing 10-K Annual Report for the fiscal year ending Friday, September 30, 2022

SEC Filings

RGIN Annual Reports

Regenicin, Inc.

CIK: 1412659 Ticker: RGIN
Cover - USD ($)
12 Months Ended
Sep. 30, 2022
Dec. 31, 2022
Cover [Abstract]  
Document Type10-K 
Amendment Flagfalse 
Document Annual Reporttrue 
Document Transition Reportfalse 
Document Period End DateSep. 30, 2022 
Document Fiscal Period FocusFY 
Document Fiscal Year Focus2022 
Current Fiscal Year End Date--09-30 
Entity File Number333-146834 
Entity Registrant NameRegenicin, Inc. 
Entity Central Index Key0001412659 
Entity Tax Identification Number27-3083341 
Entity Incorporation, State or Country CodeWY 
Entity Address, Address Line One10 High Court, 
Entity Address, City or TownLittle Falls, 
Entity Address, State or ProvinceNJ 
Entity Address, Postal Zip Code07424 
City Area Code973 
Local Phone Number557 8914 
Entity Well-known Seasoned IssuerNo 
Entity Voluntary FilersNo 
Entity Current Reporting StatusNo 
Entity Interactive Data CurrentNo 
Entity Filer CategoryNon-accelerated Filer 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Entity Public Float $ 1,534,830
Entity Common Stock, Shares Outstanding 153,483,050
Auditor NameN/A 
Auditor Firm ID9999 
Auditor LocationN/A 

View differences made from one year to another to evaluate Regenicin, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Regenicin, Inc..


Assess how Regenicin, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Regenicin, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Regenicin, Inc. provided additional information to their SEC Filing as exhibits

Ticker: RGIN
CIK: 1412659
Form Type: 10-K Annual Report
Accession Number: 0001662252-23-000007
Submitted to the SEC: Fri Jan 13 2023 2:36:54 PM EST
Accepted by the SEC: Fri Jan 13 2023
Period: Friday, September 30, 2022
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: